LLY
Eli Lilly & Co Health Care Pharmaceutical Preparations S&P 500Russell 3000
$1,417.54Close
$1.3TMarket cap
$839.21 – $1,417.5452-week range
Late-januaryNext report · estimated
Highlights
Strengths
- In a stage-2 uptrend all 8 trend conditions pass
- Leading the market RS 91 · stronger than 91% of stocks over 12 months
- RS line at a 1-year high outperforming the S&P 500 more than at any point this year
- Near its high at its 52-week high
Cautions
- Extended 5.8 ATR above its 50-day average
Price
Filing Results Screen pick 52-week high and low Adjusted prices
Key figures
Off 12-month high
0%
1wk
up 11.3%
price change
1mo
up 22.5%
price change
12-month return
up 69%
market up 11% ·
its own up 64%
F-score
7 / 9
Strong
Altman Z
11.21
Low risk
P/E
64.9×
price / earnings
PEG
0.68
P/E / EPS growth
P/B
50.5×
price / book
Earnings yield
up 1.9%
EBIT / enterprise value
Cheaper than
22%
of the market · expensive
Revenue growth
up 45%
year on year
EPS growth
up 16%
latest quarter · -10 pts
Sales growth
up 39%
latest quarter · -9 pts
ROE
up 101%
return on equity
Free cash margin
up 26%
$16.8B FCF
D/E
1.54
long-term debt / equity
Net debt / EBITDA
1.2×
Interest cover
—EBIT / interest
Piotroski tests
- profits not fully backed by cash
- took on more long-term debt
- profitable on its assets
- generating cash from operations
- profitability improving
- short-term liquidity improved
- no new shares issued
- gross margin widened
- assets working harder
Repair signals
- Gross margin 81.3% → 83.0%
Trade setup
ATR%
3.2%
$44.91 a day · 2×ATR $1,327.71
RS
91 / 99
vs the universe
Trend
8 / 8
trend template
Relative volume
2.2×
vs 50-day average
Up/down volume
1.40
50 sessions
Implied move
—
no scheduled report
Trend template · 8 of 8
Screen verdict
Did not qualify for any screen.
Warning signs
- No restatement or impairment
- Equity positive
- Interest covered
- No material dilution
- Profits tracking cash
- Margins and revenue not shrinking
Last reported
Oct 29, 2026
Results reaction
Oct 29, 2026+12% vs market2 sessions after results
Options
$178.5M32.9% IV · activity
Financials
- Gross 83%
- Net 32%
- Free cash 26%
- Cash
- Long-term debt
| FY2020Dec 31, 2020 | FY2021Dec 31, 2021 | FY2022Dec 31, 2022 | FY2023Dec 31, 2023 | FY2024Dec 31, 2024 | FY2025Dec 31, 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $24.5B | $28.3B | $28.5B | $34.1B | $45.0B | $65.2B |
| Gross margin | 78% | 74% | 77% | 79% | 81% | 83% |
| Net income | $6.2B | $5.6B | $6.2B | $5.2B | $10.6B | $20.6B |
| Net margin | 25% | 20% | 22% | 15% | 24% | 32% |
| Earnings per share | $6.79 | $6.12 | $6.90 | $5.80 | $11.71 | $22.95 |
| Free cash flow | $6.5B | $7.4B | $7.6B | $4.2B | $8.8B | $16.8B |
| Free cash margin | 26% | 26% | 27% | 12% | 20% | 26% |
| Cash | $3.7B | $3.8B | $2.1B | $2.8B | $3.3B | $7.3B |
| Long-term debt | $16.6B | $15.3B | $14.7B | $18.3B | $28.5B | $40.9B |
| Shareholders' equity | $5.6B | $9.0B | $10.6B | $10.8B | $14.3B | $26.5B |
| Shares outstanding | 957.08k | 954.12m | 950.63m | 949.78m | 947.90m | 944.80m |
What options price now
- Expected 1-month range The at-the-money straddle for the expiry nearest a month out, as a share of the price: the move, either way, the option market is pricing by then. The range is the price plus and minus that move; the stock ends inside it a little more often than not. Methodology
- $1,315 – $1,514 ±7.0% by Nov 27, 2026
- Swings expected vs recent The daily swings the options are priced for (implied volatility) against the swings the stock actually had over the last 20 sessions (realised volatility). Bigger means options charge for more movement than the stock has been delivering; smaller, less. On a contract row, that contract's own implied volatility over the stock's realised. Methodology
- About the same 32.9% priced · 35.7% recent
- Next month vs later At-the-money implied volatility for 8-45 day expiries over 46-90 day ones: whether options price the coming month as choppier or calmer than the two after it. Ahead of a report it usually reads choppier, and the extra comes out once the report is out. Methodology
- About the same
- Crash protection What options that pay off in a fall cost against options that pay off in a rise (the 25-delta skew), compared with this company's own normal - the median of its stored nightly readings, once there are 20 - and with five sessions ago. Protection costs a little more than upside on most shares. More than usual means readers of the chain are paying up to insure against a drop; it does not say which way the stock will go. Methodology
- past week: no change
Positioning
- Premium traded
- $178.5M calls $142.3M · puts $36.1M · latest session
- 0.25× -0.18 over the week
- Open interest added The change over five sessions in option positions left open overnight, calls and puts. A rise means positions were added. It cannot say whether they were bought or sold, so more calls is not a vote for a rise: a call is as often sold against shares already held. Methodology
- calls -19.30k · puts -12.11k past week
For options traders: ATM IV 32.9% (-5.9% 1w) · 1m ÷ 3m IV 1.01 · 25Δ skew 2.1 pts · Net GEX $221.4M
Most traded contracts
No contract passed the liquidity filters this week.
Filings
| Filed | Report | Period to | Lag |
|---|---|---|---|
| Oct 29, 2026 | Quarterly ↗ | Sep 30, 2026 | 29d |
| Aug 5, 2026 | Quarterly ↗ | Jun 30, 2026 | 36d |
| Apr 30, 2026 | Quarterly ↗ | Mar 31, 2026 | 30d |
| Feb 12, 2026 | Annual ↗ | Dec 31, 2025 | 43d |
| Oct 30, 2025 | Quarterly ↗ | Sep 30, 2025 | 30d |
| Aug 7, 2025 | Quarterly ↗ | Jun 30, 2025 | 38d |
| May 1, 2025 | Quarterly ↗ | Mar 31, 2025 | 31d |
| Feb 19, 2025 | Annual ↗ | Dec 31, 2024 | 50d |
| Oct 30, 2024 | Quarterly ↗ | Sep 30, 2024 | 30d |
| Aug 8, 2024 | Quarterly ↗ | Jun 30, 2024 | 39d |
| Apr 30, 2024 | Quarterly ↗ | Mar 31, 2024 | 30d |
| Feb 21, 2024 | Annual ↗ | Dec 31, 2023 | 52d |
Current reports
| Filed | Disclosed |
|---|---|
| Oct 29, 2026 | Results ↗ |
| Aug 5, 2026 | Results ↗ |
| May 20, 2026 | Other events ↗ |
| May 7, 2026 | Shareholder vote ↗ |
| Apr 30, 2026 | Results ↗ |
| Feb 4, 2026 | Results ↗ |
| Nov 21, 2025 | Director or officer change ↗ |
| Oct 30, 2025 | Results ↗ |
| Aug 20, 2025 | Other events ↗ |
| Aug 7, 2025 | Results ↗ |
| May 8, 2025 | Shareholder vote ↗ |
| May 1, 2025 | Results ↗ |